Market Research Logo

Molecular Testing Markets for Infectious Diseases (Sepsis, Respiratory Diseases, HIV, Hepatitis, TB Testing, STIs and Other Tests)

Molecular Testing Markets for Infectious Diseases (Sepsis, Respiratory Diseases, HIV, Hepatitis, TB Testing, STIs and Other Tests)

Over half of the revenues earned in molecular diagnostics are earned by companies marketing tests to detect infectious disease. This Kalorama Information report examines the market opportunity for those tests, the companies that sell them, trends in the market and details segment-level market sizing and forecasts.

Test Segments: Market Sizing and ForecastsThere are several segments where testing at the molecular level has thrived, including the following:
  • HPV Testing
  • CT/NG Testing
  • Molecular Hepatitis Testing
  • HIV Testing
  • Hospital Acquired Infections and Sepsis Testing
  • Respiratory Diseases Testing
  • Mycobacteria/Tuberculosis Testing
The report does not contain information on blood banking, blood typing or NAT screen tests. These are covered in Kalorama Information's The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 11th Edition.

Regional Distribution

For each of these segments, the report provides a breakout for the following regions:
  • North America
  • Europe
  • Asia Pacific
  • Other
Company Profiles

Companies covered in this report include:
  • Abbott
  • bioMérieux
  • Bio-Rad
  • Cepheid
  • Meridian
  • Qiagen
  • Quidel
  • Roche


  • Executive Summary
    • The Global Infectious Disease Molecular Diagnostics Market
      • Table Molecular Infectious Disease Market, 2019-2014
    • Test Segments
    • Emerging Trends Influencing the Market Landscape
  • Developments in Molecular Infectious Disease Testing
    • Molecular POC: Upstart Competitors
    • Prospects for Molecular POC Testing for Infectious Diseases Diagnostics
      • Table Selected Molecular POC Platforms in the Market for Infectious Disease Testing
    • Increased Presence of STDs
    • Lyme Disease: Major IVD Leaps in with Molecular Solutions
    • New Fungal Infection Spotlights Mass Spec and Sequencing
    • Updated Influenza Guidelines from the Infectious Diseases Society of America
    • PCR-based Assay for Diagnosis of Bacteremia Beats Blood Cultures in Study
    • Meridian Acquires GenePOC
    • T2Bacteria Study Demonstrates Worth in Recent Study
    • Bruker Completes Acquisition of Majority Interest in Infectious Disease Molecular Diagnostics Company Hain Lifescience GmbH
    • Reimbursement Environment for Molecular Diagnostics
    • New Project Uses Sequencing for TB Diagnosis in Emerging Nations
    • Growing Microhospital Business Beckons Clinical Labs
    • New Eight Bacteria Gram-Negative Test Cleared by FDA
    • Clinical Utility of Molecular Diagnostics
    • AI Assisting with Molecular Colorectal Diagnosis
  • Markets for Molecular Infectious Disease Diagnostics
    • Table Selected Integrated Clinical Molecular Systems in the Market for Infectious Disease Diagnostics
    • Market Analysis - Global
      • Table Market by Segments (%) (HIV and Hepatitis, Hospital, STIs and HPV, Other)
      • Table Global Molecular Infectious Disease Diagnostics Markets (2019-2024), by Infection ($, Million) (Hepatitis, HIV, HAIs/Sepsis, HPV, CT/NG, Respiratory Diseases, Mycobacteria/TB, Other, Total)
      • Table Global Molecular Infectious Disease Diagnostics Markets, by Region (2019-2024) ($, Million) (North America, Europe, APAC, RoW, Total)
      • CT/NG, HPV and Women's Health
        • Table Global Molecular HPV Testing Markets, by Region (2019-2024) ($, Million) (North America, Europe, APAC, RoW, Total)
        • Table Global Molecular CT/NG Testing Markets, by Region (2019-2024) ($, Million) (North America, Europe, APAC, RoW, Total)
      • Hepatitis
        • Table Global Molecular Hepatitis Testing Markets, by Region (2019-2024) ($, Million) (North America, Europe, APAC, RoW, Total)
      • HIV
        • Table Innovations in Molecular POC Diagnostics for HIV
        • Table Global Molecular HIV Testing Markets, by Region (2019-2024) ($, Million) (North America, Europe, APAC, RoW, Total)
      • Hospital-Acquired Infections (HAIs)
        • Table Global Molecular HAIs/Sepsis Testing Markets, by Region (2019-2024) ($, Million) (North America, Europe, APAC, RoW, Total)
      • Respiratory Diseases
        • Table Global Molecular Respiratory Diseases Testing Markets, by Region (2019-2024) ($, Million) (North America, Europe, APAC, RoW, Total)
      • Mycobacteria/Tuberculosis
        • Table Global Molecular Mycobacteria/TB Testing Markets, by Region (2019-2024) ($, Million) (North America, Europe, APAC, RoW, Total)
  • Company Profiles
    • Abbott Diagnostics
      • The Molecular Diagnostics Business Post-Acquisition of Alere
    • Becton, Dickinson & Co. (BD)
      • Business Segments
      • Molecular Diagnostics Focus
    • bioMérieux
      • Molecular
    • Bio-Rad Laboratories
    • Danaher (Cepheid and Leica Biosystems)
      • Life Sciences Business
      • Diagnostics Business
      • Cepheid
      • Leica Biosystems
      • Danaher's 2018 Performance and 2019 Expectations
      • Acquisitions and Divestments in 2018 / 2019
    • Meridian Bioscience Inc
    • QIAGEN N.V.
      • Consumables and Related Revenues
      • Automation Platform and Instrumentation
      • Molecular Diagnostics Applications
      • Applied Testing
      • Pharma and Academia
      • New Developments (in 2018 until mid-2019)
      • Developments in Automation Systems
      • Bioinformatics Solutions
    • Quidel Corporation
    • Roche Diagnostics
      • Global Access Program for HIV
      • Core Molecular
      • cobas Liat System - POC
      • Partnering with Information Technology
      • Product Launches in 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report